-
Je něco špatně v tomto záznamu ?
Effects of different hemodialysis modalities combined with low-calcium dialysate on mineral metabolism and vascular calcification in maintenance hemodialysis patients with chronic kidney disease
J. Wang, Y. Luo, X. Ji, H. Xu, Z. Liang, M. Zhou
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, randomizované kontrolované studie
Grantová podpora
2022A029
President Foundation of Nanfang Hospital, Southern Medical University - China
NLK
Directory of Open Access Journals
od 2019
ROAD: Directory of Open Access Scholarly Resources
od 2002
PubMed
40033811
DOI
10.32725/jab.2024.027
Knihovny.cz E-zdroje
- MeSH
- C-reaktivní protein metabolismus analýza MeSH
- chronická renální insuficience * terapie krev komplikace metabolismus MeSH
- dialýza ledvin * škodlivé účinky MeSH
- dialyzační roztoky farmakologie MeSH
- dospělí MeSH
- fosfor krev MeSH
- interleukin-6 krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- minerály metabolismus krev MeSH
- parathormon krev MeSH
- senioři MeSH
- TNF-alfa krev MeSH
- vápník * krev metabolismus MeSH
- vaskulární kalcifikace * krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
OBJECTIVE: This research investigated the effects of different hemodialysis modalities combined with low-calcium dialysate (LCD) on mineral metabolism and vascular calcification (VC) in maintenance hemodialysis (MHD) patients with chronic kidney disease (CKD). METHODS: General data were collected from 192 cases of MHD patients, who were divided into 4 groups according to the randomized numerical table. Each group was given LCD treatment, and conventional hemodialysis (HD), high-flux HD (HFHD), hemodiafiltration (HDF), and HD + hemoperfusion (HP) were performed, respectively. The patients were dialyzed 3 times per week for 4 h each time, and each group was treated for 6 months. Fasting venous blood was collected. Serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitive C-reactive protein (hs-CRP) levels were measured by ELISA, calcium (Ca2+), phosphorus (P), Ca2+-P product, serum creatinine (SCr), blood urea nitrogen (BUN), β2 microglobulin (β2-MG), and intact parathyroid hormone (iPTH) were measured by chemiluminescence immunoassay, serum alkaline phosphatase (ALP) was determined by turbidimetric assay, and 25-hydroxyvitamin D (25(OH)D) was measured by autoradiographic immunoassay. To assess the extent of calcification in the iliac artery and abdominal aorta, a multilayer spiral CT device was employed for abdominal scans. RESULTS: Serum IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP levels decreased, while 25(OH)D levels increased in the four groups after treatment. The most pronounced effect on the reduction of IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP was in the HD + HP group, followed by the HDF and HFHD groups, and then by the HD group. The rate of VC in the HDF, HFHD, and HD + HP groups was lower than that in the HD group, and the rate in the HD + HP group was lower than that in the HDF and HFHD groups. CONCLUSION: The combination of HD + HP and LCD in treating CKD with MHD is effective, evidently rectifying disruptions in serum Ca2+ and P metabolism, enhancing kidney function, lessening the body's inflammatory response, and lessening VC.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25011851
- 003
- CZ-PrNML
- 005
- 20250521143007.0
- 007
- ta
- 008
- 250506s2024 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2024.027 $2 doi
- 035 __
- $a (PubMed)40033811
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Wang, Jing $u Southern Medical University, Nanfang Hospital, Blood Purification Unit, Guangzhou 510515, Guangdong China
- 245 10
- $a Effects of different hemodialysis modalities combined with low-calcium dialysate on mineral metabolism and vascular calcification in maintenance hemodialysis patients with chronic kidney disease / $c J. Wang, Y. Luo, X. Ji, H. Xu, Z. Liang, M. Zhou
- 520 9_
- $a OBJECTIVE: This research investigated the effects of different hemodialysis modalities combined with low-calcium dialysate (LCD) on mineral metabolism and vascular calcification (VC) in maintenance hemodialysis (MHD) patients with chronic kidney disease (CKD). METHODS: General data were collected from 192 cases of MHD patients, who were divided into 4 groups according to the randomized numerical table. Each group was given LCD treatment, and conventional hemodialysis (HD), high-flux HD (HFHD), hemodiafiltration (HDF), and HD + hemoperfusion (HP) were performed, respectively. The patients were dialyzed 3 times per week for 4 h each time, and each group was treated for 6 months. Fasting venous blood was collected. Serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitive C-reactive protein (hs-CRP) levels were measured by ELISA, calcium (Ca2+), phosphorus (P), Ca2+-P product, serum creatinine (SCr), blood urea nitrogen (BUN), β2 microglobulin (β2-MG), and intact parathyroid hormone (iPTH) were measured by chemiluminescence immunoassay, serum alkaline phosphatase (ALP) was determined by turbidimetric assay, and 25-hydroxyvitamin D (25(OH)D) was measured by autoradiographic immunoassay. To assess the extent of calcification in the iliac artery and abdominal aorta, a multilayer spiral CT device was employed for abdominal scans. RESULTS: Serum IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP levels decreased, while 25(OH)D levels increased in the four groups after treatment. The most pronounced effect on the reduction of IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP was in the HD + HP group, followed by the HDF and HFHD groups, and then by the HD group. The rate of VC in the HDF, HFHD, and HD + HP groups was lower than that in the HD group, and the rate in the HD + HP group was lower than that in the HDF and HFHD groups. CONCLUSION: The combination of HD + HP and LCD in treating CKD with MHD is effective, evidently rectifying disruptions in serum Ca2+ and P metabolism, enhancing kidney function, lessening the body's inflammatory response, and lessening VC.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a dialýza ledvin $x škodlivé účinky $7 D006435
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a vápník $x krev $x metabolismus $7 D002118
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a vaskulární kalcifikace $x krev $7 D061205
- 650 12
- $a chronická renální insuficience $x terapie $x krev $x komplikace $x metabolismus $7 D051436
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a minerály $x metabolismus $x krev $7 D008903
- 650 _2
- $a TNF-alfa $x krev $7 D014409
- 650 _2
- $a interleukin-6 $x krev $7 D015850
- 650 _2
- $a dialyzační roztoky $x farmakologie $7 D015314
- 650 _2
- $a fosfor $x krev $7 D010758
- 650 _2
- $a parathormon $x krev $7 D010281
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a C-reaktivní protein $x metabolismus $x analýza $7 D002097
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Luo, Yimian $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Ji, Xingyu $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Xu, Hao $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Liang, Zhenhua $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Zhou, Minjie $u Southern Medical University, Nanfang Hospital, Department of Organ Transplantation, Guangzhou 510515, Guangdong, China
- 773 0_
- $w MED00012667 $t Journal of applied biomedicine $x 1214-0287 $g Roč. 22, č. 4 (2024), s. 228-233
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40033811 $y Pubmed
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y p $z 0
- 990 __
- $a 20250506 $b ABA008
- 991 __
- $a 20250521143005 $b ABA008
- 999 __
- $a ok $b bmc $g 2324879 $s 1248941
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 22 $c 4 $d 228-233 $e 20241216 $i 1214-0287 $m Journal of applied biomedicine $n J Appl Biomed $x MED00012667
- GRA __
- $a 2022A029 $p President Foundation of Nanfang Hospital, Southern Medical University $2 China
- LZP __
- $b NLK124 $a Pubmed-20250506